Us Weekly3d
Death of Brett Gardner’s 14-Year-Old Son Miller: What We Know and What We Still Need Answered
The death of former New York Yankees star Brett Gardner’s 14-year-old son, Miller, left as many confounding questions as it ...
Brett Gardner And Family Receive Troubling Autopsy Update In Son’s Death
Retired MLB star Brett Gardner and his wife are facing yet another emotional hurdle in the tragic loss of their 14-year-old ...
Worried about being ‘glutened?’ Here’s how to dine out with ease while gluten-free
When at the grocery store, she suggests looking for certified gluten-free symbols, such as when picking up condiments - “soy ...
Clinical Advisor16d
An Overview of Addison Disease
Primary care clinicians are often the most accessible to patients and play a crucial role in the early detection and treatment of Addison Disease.
Crux26d
Venezuelans wait for canonization of folk saint José Gregório
“As a University professor in Caracas, he was the founder of the histology course ... In 2016, when he was 20, Diomedes began to feel stomach ache with a certain frequency.
The American Journal of Managed Care4d
FDA Approves Durvalumab Combo for Muscle-Invasive Bladder Cancer
The approval follows the December 2024 priority review designation for this perioperative immunotherapy regimen for patients fighting muscle-invasive bladder cancer (MIBC).
Us Weekly on MSN3d
Death of Brett Gardner's Son: What We Know and What We Still Need Answered
The death of former New York Yankees star Brett Gardner's 14-year-old son, Miller, left as many confounding questions as it ...
Le Lézard4d
TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer
Genmab A/S announced today that the European Commission (EC) has granted marketing authorization for TIVDAK® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy treatment for adult ...
Pharmabiz5d
EMA committee recommends approval of Bristol Myers Squibb’s subcutaneous formulation of Opdivo across multiple solid tumour indications
EMA committee recommends approval of Bristol Myers Squibb’s subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Monday, March 31, ...